Phase 2 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a specific gene change (mutation) in a gene called BAG3 that is known or likely to cause health problems
- You have been diagnosed with a type of heart condition called dilated cardiomyopathy (DCM), where the heart is enlarged and does not pump well
- You are on a stable combination of standard medications for heart failure
- Your heart can be clearly seen using an ultrasound scan (echocardiography)
Who may not be able to join:
- Your body has already developed immune defenses (antibodies) against a substance called AAV9, which is used to deliver the treatment
- You have a harmful gene change in a different gene (other than BAG3) that is also a recognised cause of dilated cardiomyopathy
- Your heart failure is currently unstable or has recently gotten significantly worse (known as decompensated heart failure)
Important: Always verify eligibility with the trial site directly before applying.
Note: This list may not cover all eligibility requirements. Additional criteria may apply that are not listed here — please confirm all details with the trial site.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-855-752-2356
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part A: Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.